Alpine Income Property Trust Inc (PINE) said after close Thursday that it earned $0.37 per share in quarter three 2023.
On the revenue line, the company reported $11.6 million, missing estimates by $131 thousand.
In the same quarter a year ago, the company earned $0.4 per share on revenue of $11.5 million.
The stock is down 8.68% to $15.15 after the report.
Despite revenues increasing, earnings decreased, signaling a decline in profit margins.
Wall Street Analysts had an average rating of Buy on the stock prior to the report.
Trading in the five days leading up to the report earned Alpine Income Property Trust Inc a Bearish Sentiment Rank from InvestorsObserver.
Prior to the report, InvestorsObserver gave the stock an overall score of 55. Meanwhile, the average Wall Street analyst rated the stock a Buy.
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.
News Home
Alpine Income Property Trust Inc Down 8.68% To $15.15 After Earnings
Mentioned in this article
